Saffron is derived from the stigma of the crocus flower (Crocus sativus) and contains antioxidant carotenoids, primarily crocins, picrocrocin, and safranal. Crocins provide saffron's characteristic yellow-orange color, picrocrocin its bitter taste, and safranal much of its aroma [1].
Saffron has been studied primarily for depression, anxiety, sleep, cognitive function, vision, and appetite regulation, with most evidence coming from small, short-term, manufacturer-funded trials.
Table of Contents
- Overview
- Forms and Bioavailability
- Evidence for Benefits
- Recommended Dosing
- Safety and Side Effects
- Drug Interactions
- Dietary Sources
- References
Overview
Saffron is derived from the stigma of the crocus flower (Crocus sativus) and contains antioxidant carotenoids, primarily crocins, picrocrocin, and safranal. Crocins provide color, picrocrocin provides its bitter taste, and safranal provides much of its aroma. Picrocrocin consists of safranal attached to a sugar molecule (45.47% of picrocrocin is safranal) [1].
The amounts of these active compounds vary significantly by geographic location. Picrocrocin is considered unique to saffron and is therefore the best authenticity biomarker [2].
Looking for Evidence-Based Mood Support?
Saffron shows promise for mood and sleep, but its not the only option. Get personalized supplement guidance based on your health profile with Health Roadmap.
Get Your Personalized Health PlanSaffron has been studied primarily for depression, anxiety, sleep, cognitive function, vision, and appetite regulation, with most evidence coming from small, short-term, manufacturer-funded trials.
Forms and Bioavailability
Saffron supplements typically contain extracts rather than whole saffron powder, standardized to specific concentrations of active compounds:
- Affron — standardized to 3.5% "Lepticrosalides" (reportedly total crocins, picrocrocin, and safranal). Used in most depression and sleep studies at 14 mg twice daily.
- Safr'Inside — standardized to >3% crocins and >0.2% safranal. Used in mood and stress studies at 15 mg twice daily.
- Satiereal / Supresa — standardized to 0.3% safranal. About 6–7 times less concentrated than Affron. Used in appetite studies at 88.25 mg twice daily.
- Saffr'activ — standardized to approximately 6% crocins and 4.5% safranal.
Important labeling caveat: standardized percentages are sometimes based on UV-Vis spectrophotometry, which can vastly overestimate actual amounts — one study found UV-Vis values for safranal to be 5 to 150 times higher than HPLC values [3].
Safranal is fat-soluble; take saffron with a meal containing fats or oils to maximize absorption. Crocins are water-soluble and do not require fat for absorption.
Evidence for Benefits
Depression and Anxiety
Several clinical studies suggest modest benefits for depression, with saffron compounds speculated to work by inhibiting the reuptake of dopamine, norepinephrine, and serotonin [4].
A two-month study of 80 adolescents with mild-to-moderate anxiety and/or depression found that 14 mg of affron twice daily decreased self-reported symptoms by 33% versus 17% with placebo [5].
In 139 adults still experiencing depression despite antidepressant medication, adding 14 mg of affron twice daily for two months led to clinician-rated improvement in 40% versus 24% with placebo. However, there was no improvement based on patients' own symptom ratings [6].
A 12-week study of 202 adults with low mood found that 14 mg of affron twice daily produced clinically significant changes in depression symptoms in 72.3% versus 54.3% with placebo, but no significant differences in sleep, stress, anxiety, or wellbeing [7].
Sleep
Saffron extract has shown only modest and limited sleep benefits in small, manufacturer-funded trials.
A study found that 14 mg of affron twice daily for 28 days modestly reduced insomnia severity and improved sleep quality, with most improvements occurring within the first seven days [10]. A follow-up tested 14 mg and 28 mg doses, finding similar improvements in sleep quality (22% and 25% vs 8% with placebo), but neither dose improved alertness, total sleep time, sleep onset, or daytime sleepiness. Saffron modestly increased evening melatonin levels [11].
A large study of 158 adults with moderate to severe insomnia found no significant reduction in insomnia symptoms with 20 or 30 mg/day of Safr'Inside for four weeks [13].
Cognitive Function and Alzheimer's Disease
A review of three clinical trials found saffron appeared beneficial for Alzheimer's or mild cognitive impairment, but a definitive conclusion could not be drawn [14]. Only one had a placebo control; it showed better cognitive outcomes over 16 weeks in mild to moderate Alzheimer's, though marked decline in the placebo group contributed to the relative improvement [15].
Vision
Several small studies suggest that 20 mg/day of saffron extract for 3–12 months can modestly improve retinal sensitivity and visual acuity in early age-related macular degeneration [18][19][20]. A study of 100 adults with mild to moderate AMD found that 20 mg/day for three months modestly improved visual acuity compared to placebo [21].
Weight, Appetite, and Fatty Liver
An 8-week study of 61 mildly overweight women found that 176.5 mg/day of Satiereal did not reduce weight, though it appeared to reduce snacking [22]. A 3-month study of 72 adults with MASLD found that 100 mg/day of saffron powder (alongside diet and exercise) produced greater reductions in liver fat (41% vs 27%), cholesterol, and triglycerides, but did not reduce weight or liver fibrosis [23].
Recommended Dosing
- Affron extract: 14 mg twice daily (most studied dose for depression and sleep)
- Safr'Inside extract: 15 mg twice daily or 30 mg once daily
- Satiereal / Supresa: 88.25 mg twice daily (appetite)
- Vision/cognition: 15–20 mg twice daily
Take with a fat-containing meal to optimize absorption of fat-soluble safranal.
Safety and Side Effects
At standard dosing, significant side effects have not been reported, though studies have been short-term. Safety in children and pregnant or nursing women has not been evaluated.
Saffron may have a blood-thinning effect, though evidence is mixed. Modest decreases in platelet counts have been reported at 60–100 mg/day, but these were not significant compared to placebo [24][25]. One case report documented bleeding complications in a patient taking a crocin supplement alongside rivaroxaban [26].
Drug Interactions
- Blood thinners (anticoagulants): Saffron may enhance anticoagulation effects, particularly with rivaroxaban and warfarin [26].
- Antidepressants: Saffron may enhance the effects of SSRIs through its effects on serotonin, dopamine, and norepinephrine reuptake. Physician supervision is advised [6].
Dietary Sources
Saffron is used as a culinary spice worldwide, particularly in Middle Eastern, Indian, and Mediterranean cuisines. Iran is the world's largest producer. Culinary doses (typically a few threads per dish, providing milligram-level quantities) are far lower than the extract doses used in clinical trials.
Looking for Evidence-Based Mood Support?
Saffron shows promise for mood and sleep, but its not the only option. Get personalized supplement guidance based on your health profile with Health Roadmap.
Get Your Personalized Health PlanReferences
1. Jarukas L et al., Molecules, 2022.
2. Chyau CC et al., Plants, 2022.
3. Garcia-Rodriguez MV et al., Food Chem, 2017.
4. Akhondzadeh S et al., BMC Complement Altern Med, 2004.
5. Lopresti AL et al., J Affect Disord, 2018.
6. Lopresti AL et al., J Psychopharmacol, 2019.
7. Lopresti AL et al., J Nutr, 2025.
8. Jackson PA et al., Front Nutr, 2021.
9. Amadieu C et al., Am J Clin Nutr, 2025.
10. Lopresti AL et al., J Clin Sleep Med, 2020.
11. Lopresti AL et al., Sleep Med, 2021.
12. Pachikian BD et al., Nutrients, 2021.
13. Schuster AK et al., Sleep Med X, 2025.
14. Ayati Z et al., BMC Comp Med Ther, 2020.
15. Akhondzadeh S et al., J Clin Pharm Ther, 2010.
16. Farokhnia M et al., Hum Psychopharmacol, 2014.
17. Akhondzadeh S et al., Psychopharmacol, 2010.
18. Falsini B et al., Invest Ophthalmol Vis Sci, 2010.
19. Piccardi M et al., Evid Based Complement Alternat Med, 2012.
20. Marangoni D et al., J Transl Med, 2013.
21. Broadhead GK et al., Graefes Arch Clin Exp Ophthalmol, 2019.
22. Gout B et al., Nutr Res, 2010.
23. Parsa S et al., J Herb Med, 2024.
24. Safarinejad MR et al., Int J Impot, 2010.
25. Kianbakht S et al., Phytother Res, 2011.
26. Heidari S et al., Cardiovasc Hematol Disord Drug Targets, 2022.
